Wolverine Asset Management LLC Halozyme Therapeutics, Inc. Put Options Transaction History

Wolverine Asset Management LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 01, 2024	SELL	$33.32 - $42.1 $13,328 - $16,840	-400 Reduced 2.23%	17,500 $646,000
Q2 2023 Aug 07, 2023	BUY	$30.28 - $38.74 $542,012 - $693,446	17,900 New	17,900 $645,000
Q4 2020 Feb 12, 2021	SELL	$25.81 - $43.62 $498,133 - $841,866	-19,300 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$25.74 - $29.63 $48,906 - $56,297	-1,900 Reduced 8.96%	19,300 $507,000
Q2 2020 Aug 13, 2020	BUY	$16.25 - $26.81 $344,500 - $568,372	21,200 New	21,200 $568,000

542

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.36B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.